KRT20 and lung carcinoma: Previous investigation has indicated that a fragment of CK is a characteristic protein component of epithelial cells, whose abnormal elevation may be potentially associated with the development of various types of lung cancer, therefore, blocking the expression of CK7 and CK20 may be workable for the inhibition of the carcinogenesis process and beneficial for the development of anticancer treatment strategies [28–30].